Cardio-oncology:An ongoing evolution

Petek, Bradley J., Greenman, Chris, Herrmann, Joerg, Ewer, Michael S. and Jones, Robin L. (2015) Cardio-oncology:An ongoing evolution. Future Oncology, 11 (14). pp. 2059-2066. ISSN 1479-6694

Full text not available from this repository.

Abstract

Cancer survivorship has been greatly impacted with the development of modern cancer treatments. While significant strides have been made in managing many types of cancer, now physicians face new challenges. Over the past decades, cardiovascular events in cancer survivors have increased in prevalence, driving the development of multidisciplinary cardio-oncology programs. Additionally, as cancer patients live longer, their risk of developing secondary cardiovascular events increases. The rapid development of novel cancer therapies will continue to generate questions of cardiac risk and cardiac protection in cancer patients over time. We wish to outline the development of cardio-oncology in its present state, and provide future perspectives for the discipline.

Item Type:	Article
Additional Information:	Publisher Copyright: © 2015 Future Medicine Ltd.
Uncontrolled Keywords:	anthracycline,cancer therapy,cardio-oncology,cardiotoxicity,oncology,cancer research,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2730
Related URLs:	https://www.scopus.com/pages/publication...
Depositing User:	LivePure Connector
Date Deposited:	06 Aug 2026 11:12
Last Modified:	10 Aug 2026 00:02
URI:	https://ueaeprints.uea.ac.uk/id/eprint/104013
DOI:	10.2217/fon.15.89

Actions (login required)

View Item